Tata Sons to Scale-up Covid-19 Testing Kit ‘Feluda’

Tata Sons to Scale-up Covid-19 Testing Kit ‘Feluda’

  • Research Stash
  • News
  • 1.9K

The Institute of Genomics and Integrative Biology (IGIB), has transferred the technology Feluda (FNCAS9 Editor Linked Uniform Detection Assay) to Tata Sons for further development and commercialization. A memorandum of understanding reflecting the arrangement has been signed between the two institutions. Feluda is a rapid diagnostic kit for COVID-19, developed indigenously by IGIB, a CSIR institution.

The main advantages of Feluda are its affordability, relative ease of use, and non-dependency on expensive Q-PCR machines.

“Innovative ‘Feluda’ test uses cutting-edge Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology for detection of the genomic sequence of the novel coronavirus. It uses a test protocol that is simple to administer and easy to interpret enabling results to be made available to the medical fraternity in relatively lesser time, as compared to other test protocols”, said Banmali Agrawala, President – Infrastructure and Defence & Aerospace, Tata Sons.

Dr. Anurag Agrawal, Director-IGIB highlighted that the technology was conceived and developed at CSIR IGIB under sickle cell mission and utilizes an indigenously developed cutting edge CRISPR Cas9 technology to specifically recognize COVID-19 sequence in a sample. A combination of CRISPR biology and paper-strip chemistry leads to a visible signal readout on a paper strip that can be rapidly assessed for establishing the presence of viral infection in a sample.

“CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting-edge technology and I am happy to see that a leading industry group the Tata Sons is partnering towards its deployment. The strong partnership with industry in tackling COVID-19 has been the hallmark of CSIR’s strategy in mitigation of COVID-19”, said Dr. Shekhar C. Mande, DG-CSIR.

“We are happy to have a partnership with the CSIR for further development and commercialization of the technology for COVID-19 detection. We believe that CRISPR is a futuristic technology that can also be configured for the detection of multiple other pathogens in the future,” added Agrawala. (ISW)

Umashankar Mishra

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

Dr. Anurag Agrawal, Director-IGIB highlighted that the technology was conceived and developed at CSIR IGIB under sickle cell mission and utilizes an indigenously developed cutting edge CRISPR Cas9 technology to specifically recognize COVID-19 sequence in a sample. A combination of CRISPR biology and paper-strip chemistry leads to a visible signal readout on a paper strip that can be rapidly assessed for establishing the presence of viral infection in a sample.

“CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting-edge technology and I am happy to see that a leading industry group the Tata Sons is partnering towards its deployment. The strong partnership with industry in tackling COVID-19 has been the hallmark of CSIR’s strategy in mitigation of COVID-19”, said Dr. Shekhar C. Mande, DG-CSIR.

“We are happy to have a partnership with the CSIR for further development and commercialization of the technology for COVID-19 detection. We believe that CRISPR is a futuristic technology that can also be configured for the detection of multiple other pathogens in the future,” added Agrawala. (ISW)

Umashankar Mishra

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

" }
Freshly harvested fruits

Wild Blood Fruit A Source of Natural Red Colourant May Be Domesticated

Blood fruit is a woody climber and it is very popular among tribes in the Northeastern states, Andaman and Nicobar Islands and Bangladesh. The fruit is not only tasty and rich in anti-oxidant but is also a good source of dye for the local handicraft industry.  Now researchers have developed a standard nursery protocol for its propagation.

  • News
  • 2.2K
Read more
Digital Surveillance to Monitor and Control COVID-19 Spread

Digital Surveillance to Monitor and Control COVID-19 Spread

The Centre for Cellular and Molecular Biology and the Institute of Genetics and Integrated Biology, along with a few other institutions, are working for the digital and molecular surveillance of the spread of novel coronavirus to understand the biology, epidemiology and disease impact

  • News
  • 1.3K
Read more

President Tsai Highlights Progress In Fostering Biomedical Sector

President Tsai Ing-wen said June 26 that the government is committed to fostering Taiwan’s potential-laden biomedical and pharmaceuticals sector through such measures as strengthening local companies’ positions in international markets and bolstering inter ministerial collaboration on industry development initiatives.

  • News
  • 1.5K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit